InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $190.600 2.83 (1.46%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19,912 PME Cleansing Notice - Anthony Hall 21 Nov 2023 12:20PM $88.490 $190.600 risen by 115.39%
$19,912 Change of Director's Interest Notice - Sam Hupert 21 Nov 2023 12:17PM $87.920 $190.600 risen by 116.79%
$19,912 Change of Director's Interest Notice - Anthony Hall 21 Nov 2023 12:14PM $87.920 $190.600 risen by 116.79%
$19,912 Sale of 1M shares each by founders 21 Nov 2023 12:12PM $87.920 $190.600 risen by 116.79%
$19,912 Results of AGM - 2023 20 Nov 2023 12:12PM $87.840 $190.600 risen by 116.99%
$19,912 AGM Presentation - 2023 20 Nov 2023 10:05AM $87.540 $190.600 risen by 117.73%
$19,912 PME signs A$20M, 8-year contract with OHSU 13 Nov 2023 9:30AM $85.180 $190.600 risen by 123.76%
$19,912 PME signs AUD$16M, 8-year contract with South Shore Health 23 Oct 2023 9:07AM $78.160 $190.600 risen by 143.86%
$19,912 Notice of Annual General Meeting and Proxy Form 19 Oct 2023 9:28AM $80.320 $190.600 risen by 137.30%
$19,912 PME Annual General Meeting virtual online guide 19 Oct 2023 9:25AM $80.320 $190.600 risen by 137.30%
$19,912 AGM Date 10 Oct 2023 9:15AM $82.890 $190.600 risen by 129.94%
$19,912 PME signs AUD$140M, 10-year deal with Baylor Scott & White 26 Sep 2023 9:33AM $71.190 $190.600 risen by 167.73%
$19,912 Notification regarding unquoted securities - PME 30 Aug 2023 10:43AM $74.140 $190.600 risen by 157.08%
$19,912 Notification of cessation of securities - PME 28 Aug 2023 11:37AM $72.540 $190.600 risen by 162.75%
$19,912 Application for quotation of securities - PME 28 Aug 2023 11:34AM $72.540 $190.600 risen by 162.75%
$19,912 Change of Director's Interest Notice - Anthony Hall 25 Aug 2023 12:02PM $72.575 $190.600 risen by 162.63%
$19,912 PME FY2023 Results Presentation 15 Aug 2023 11:00AM $74.020 $190.600 risen by 157.50%
$19,912 CEO Interview - FY results 15 Aug 2023 9:34AM $69.620 $190.600 risen by 173.77%
$19,912 Dividend/Distribution - PME 15 Aug 2023 9:31AM $69.620 $190.600 risen by 173.77%
$19,912 2023 Corporate Governance Statement 15 Aug 2023 9:26AM $69.620 $190.600 risen by 173.77%
$19,912 Appendix 4G 15 Aug 2023 9:25AM $69.620 $190.600 risen by 173.77%
$19,912 Annual Report 2023 15 Aug 2023 9:24AM $69.620 $190.600 risen by 173.77%
$19,912 PME Full year results 15 Aug 2023 9:18AM $69.620 $190.600 risen by 173.77%
$19,912 Preliminary Final Report 15 Aug 2023 9:12AM $69.620 $190.600 risen by 173.77%
$19,912 PME signs A$24M, 7-year deal with Memorial Sloan Kettering 27 Jul 2023 9:02AM $66.950 $190.600 risen by 184.69%

201 - 225 of 679 results

Page 9 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.